Atara Biotherapeutics Inc.
ATRA | NASDAQ
$8.01
-$0.52 (-6.10%)
At close: Oct 30, 2026, 4:00 PM ET
$8.01
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 4:27 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 6.93 | -1.17 | -0.20 | -1.47 | -4.34 | -4.74 |
PEG Ratio | -0.06 | 0.01 | -0.01 | 0.04 | 0.35 | 0.18 |
PS Ratio | 1.88 | 0.77 | 6.34 | 5.26 | 72.58 | n/a |
PB Ratio | -5.89 | -1.02 | -0.55 | 2.64 | 5.28 | 3.14 |
P/FCF Ratio | -4.45 | -1.45 | -0.28 | -1.22 | -6.39 | -7.84 |
P/OCF Ratio | -4.45 | -1.45 | -0.28 | -1.24 | -6.69 | -8.03 |
OCF/S Ratio | -42.18 | -53.29 | -2.25K | -425.38 | -1.08K | n/a |
Debt / Equity Ratio | -1.37 | -0.45 | -0.58 | 0.57 | 0.10 | 0.03 |
Quick Ratio | 0.82 | 0.40 | 0.65 | 3.72 | 3.64 | 6.31 |
Current Ratio | 0.82 | 0.48 | 0.72 | 3.74 | 3.64 | 6.31 |
Asset Turnover | 5.97 | 1.18 | 0.05 | 0.17 | 0.04 | n/a |
Interest Coverage | 9.46 | -18.08 | -52.22 | -752.05 | n/a | n/a |
Return on Equity | -84.90% | 87.79% | 278.27% | -180.28% | -121.65% | -66.32% |
Return on Assets | 161.54% | -78.28% | -166.84% | -60.65% | -72.66% | -52.14% |
Return on Invested Capital | 222.66% | 721.74% | -778.42% | -90.16% | -93.25% | -60.93% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 82.44% | 83.71% | -3.65% | -324.69% | -1.29K% | n/a |
Net Profit Margin | 27.07% | -66.23% | -3.22K% | -359.12% | -1.67K% | n/a |
Pretax Profit Margin | 27.09% | -66.24% | -3.22K% | -359.10% | -1.67K% | n/a |
Operating Profit Margin | 29.69% | -64.71% | -3.22K% | -441.25% | -1.67K% | n/a |
FCF Margin | -42.18% | -53.48% | -2.27K% | -431.98% | -1.14K% | n/a |
EBITDA Margin | 31.98% | -58.75% | -3.1K% | -349.62% | -1.63K% | n/a |
Add to Watchlist
Select watchlists to add or remove ATRA